Quick Summary
- Hosted by Department of Biochemistry and Molecular Medicine
- Krebs, founding chair of biological chemistry, won Nobel in 1992
- Doudna, of UC Berkeley, won her prize in 2020 for CRISPR-Cas9
Updated 8 a.m. May 2: With in-person capacity having been reaached, the organizers have added a livestream option.
A symposium named after Edwin G. Krebs, the only Nobel laureate to date from ºÙºÙÊÓƵ, will feature a keynote address by UC Berkeley Nobel Laureate Jennifer Doudna.
The inaugural , hosted by the School of Medicine’s Department of Biochemistry and Molecular Medicine, is scheduled from noon to 5 p.m. Monday, May 15, at the on the Davis campus.
Doudna, a biochemist, is a Howard Hughes Medical Institute Investigator and founder of the Innovative Genomics Institute at Berkeley.
She won the sharing it with colleague Emmanuelle Charpentier, for the co-development of CRISPR-Cas9. The genome editing breakthrough has revolutionized biomedicine, enabling scientists to change or remove genes quickly and with great precision.
Krebs (1918-2009) was the founding chair of biological chemistry in the School of Medicine, serving from 1968 to 1977 when he returned to the University of Washington. He shared the with Edmond H. Fischer for “their discoveries concerning reversible protein phosphorylation as a biological regulatory mechanism."
Attendance at the Krebs Symposium is limited to 250 people. Lunch will be provided at the beginning of the event. Faculty, postdoctoral scholars, staff and students are invited to sign up with their ºÙºÙÊÓƵ email address . The deadline for registration is Monday (May 1).
For more information, send an email to Adriane Joo, chief administrative officer for the Department of Biochemistry and Molecular Medicine.
Lisa Howard is a senior public information officer in ºÙºÙÊÓƵ Health Communications and Media Relations. She can be reached at 916-752-6394 or lehoward@ucdavis.edu.